BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31400228)

  • 1. Left Ventricular Assist Device Therapy in Older Adults: Addressing Common Clinical Questions.
    DeFilippis EM; Nakagawa S; Maurer MS; Topkara VK
    J Am Geriatr Soc; 2019 Nov; 67(11):2410-2419. PubMed ID: 31400228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
    Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and Treatment of Right Ventricular Failure During Left Ventricular Assist Device Therapy.
    Raina A; Patarroyo-Aponte M
    Crit Care Clin; 2018 Jul; 34(3):439-452. PubMed ID: 29907275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices and their complications: A review for emergency clinicians.
    Long B; Robertson J; Koyfman A; Brady W
    Am J Emerg Med; 2019 Aug; 37(8):1562-1570. PubMed ID: 31072684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure.
    Lee SH; Doliba N; Osbakken M; Oz M; Mancini D
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):344-9. PubMed ID: 9699589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.
    Verdoorn BP; Luckhardt AJ; Wordingham SE; Dunlay SM; Swetz KM
    J Pain Symptom Manage; 2017 Aug; 54(2):231-236. PubMed ID: 28093312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dying With a Left Ventricular Assist Device as Destination Therapy.
    Dunlay SM; Strand JJ; Wordingham SE; Stulak JM; Luckhardt AJ; Swetz KM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist devices.
    Birks EJ
    Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality.
    Holley CT; Fitzpatrick M; Roy SS; Alraies MC; Cogswell R; Souslian L; Eckman P; John R
    J Heart Lung Transplant; 2017 Jan; 36(1):91-96. PubMed ID: 27623098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical challenges with the left ventricular assist device as a destination therapy.
    Rizzieri AG; Verheijde JL; Rady MY; McGregor JL
    Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.